Navigation Links
Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
Date:12/27/2011

, Germany, Distribution Share by Revenue ($m), USD Actual, 2009-2010 30

Table 16: Insulin Delivery, Germany, Distribution Share by Revenue ($m), USD Actual, 2009-2010 30

Table 17: Diabetes Care Devices, Germany, Company share by Revenue ($m), USD Actual, 2009-2010 32

Table 18: Glucose Monitoring, Germany, Company share by Revenue ($m), USD Actual 2009-2010 33

Table 19: Insulin Delivery, Germany, Company share by Revenue ($m), USD Actual 2009-2010 35

Table 20: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, 2003-2017 36

Table 21: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, Historic, 2003-2010 38

Table 22: Diabetes Care Devices, France, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 40

Table 23: Diabetes Care Devices, France, Category Volume (Units), 2003-2017 41

Table 24: Diabetes Care Devices, France, Category Volume (Units), Historic, 2003-2010 42

Table 25: Diabetes Care Devices, France, Category Volume (Units), Forecast, 2010-2017 43

Table 26: Glucose Monitoring, France, Distribution Share by Revenue ($m), USD Actual, 2009-2010 44

Table 27: Insulin Delivery, France, Distribution Share by Revenue ($m), USD Actual, 2009-2010 44

Table 28: Diabetes Care Devices, France, Company share by Revenue ($m), USD Actual, 2009-2010 46

Table 29: Glucose Monitoring, France, Company share by Revenue ($m), USD Actual 2009-2010 47

Table 30: Insulin Delivery, France, Company share by Revenue ($m), USD Actual 2009-2010 49

Table 31: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, 2003-2017 50

Table 32: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, Historic, 2003-2010 52

Table 33: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 54

Table 34: Diabetes Care Devices, Italy, Category Volume (Units), 2003-2017 55

Table 35: Diabetes Care Devic
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
3. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
4. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
5. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
6. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
7. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
8. BioMosaics Glypican-3 Blood & Tissue Tests Receive CE Marking in Europe
9. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
10. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
11. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Research and Markets has announced ... Report, 2014-2017" report to their offering. ... of reimbursement for medical expenses, the Chinese orthopedic instrument ... presenting a CAGR of 19.2% during 2009-2013. Trauma products, ... of orthopedic instruments in China , ...
(Date:8/29/2014)... 29, 2014 Does your doctor know what you,re ... have recommended marijuana to the over 112,000 currently registered patients ... majority of the other roughly 20,300+ active physicians listed with ... about it – even though a poll in February 2014 ... they have tried it. "With marijuana legalization ...
(Date:8/29/2014)... , August 29, 2014 ... by Product & Services (Equipment, Reagent, Primer, Probe, ... (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) ... the global Oligonucleotide Synthesis Market is expected to ... in 2014, growing at a CAGR of 9.8% ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
... Dec. 22, 2011 Over 130 organizations, community leaders, ... neighborhoods and inner-cities across the country today urged Express ... Walgreens. This agreement is necessary to protect access to pharmacy ... "We strongly urge Express Scripts to put the people ...
... Biopharmaceuticals Corp. ("Provenance") announced today the closing of ... LLC for the continued development of anti-cancer therapeutic, ... of molecules called immunocytokines that are being developed ... Immunocytokines, combine the immune stimulating features of cytokines ...
Cached Medicine Technology:Over 130 Community Leaders and Organizations Across the Nation Urge Express Scripts To Reach Agreement With Walgreens 2Provenance Biopharmaceuticals Corp. Announces $8M Financing Arrangement 2
(Date:8/29/2014)... 2014 Indosoft, Inc., a leading provider ... of monthly per-port licensing of its Q-Suite 5.7 software. ... solutions, Indosoft has been successfully deploying and supporting its ... contact centers around the world for more than a ... give clients another option which complements the widespread deployment ...
(Date:8/29/2014)... 29, 2014 Dr. Parsa Mohebi, founder ... rename his practice to Parsa Mohebi Hair Restoration. Since ... the needs of hair loss patients throughout Southern California. ... centers in Los Angeles, Beverly Hills, and Orange County. ... surgical treatments, many of which Dr. Mohebi perfected through ...
(Date:8/29/2014)... 29, 2014 Dr. Mohebi’s lecture on ... talked about introducing these cutting edge techniques at their ... the FUE Research Committee has allowed him the ability ... is possible with modern technology. Dr. Mohebi stated, “We ... FUE devices that facilitate extraction and implantation of hair ...
(Date:8/29/2014)... UWDress.com, one of the most famous ... collection of 2014 floor length bridesmaid dresses . ... wonderful items. According to the company’s marketing specialist, all ... discounted rate (up to 60 percent off) before September ... a special neckline: strapless, one-shoulder, bateau and more. The ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 As reported by ... Addicts' Recovery , an Ohio municipal court drug has come ... addiction. Fred Moses, who serves as the presiding judge in ... law makers to offer addicts a medicated treatment option that ... utilizes the drug known as Vivitrol, which blocks receptors in ...
Breaking Medicine News(10 mins):Health News:Indosoft Offers Monthly Usage Licensing Terms 2Health News:US Hair Restoration Changes Name to Parsa Mohebi Hair Restoration to Better Reflect Founder 2Health News:Parsa Mohebi M.D., Beverly Hills Hair Restoration Surgeon Gives Inspiring Lecture on Groundbreaking Techniques in Follicular Unit Extraction 2Health News:2014 Floor Length Bridesmaid Dresses for Sale at UWDress.com 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 3
... OXFORD, England, July 13 International medical,communications ... the Year at the Communique Awards in London ... by an independent panel of,communications experts, who assess ... for healthcare clients, along with business strategy,client retention, ...
... Gentiva Health Services, Inc. (Nasdaq: GTIV ), a ... scheduled a conference call and web cast on Thursday, July 30, 2009, ... ended June 28, 2009. Gentiva plans to issue its financial news release ... , The conference call is open to investment analysts ...
... July 13 Sunesis Pharmaceuticals, Inc. (Nasdaq: ... and commercialization of new oncology therapeutics for the treatment ... has received a $1.5 million milestone payment from Biogen ... of a Raf kinase inhibitor development candidate for the ...
... New data pooled from four large, "real world" ... VIII (rFVIII-FS) reduced bleeding and provided data regarding ... mild-to-severe hemophilia A. Additionally, rates of inhibitor formation ... untreated patients. The data were presented at the ...
... , SUNNYVALE, Calif., July 13 Cepheid (Nasdaq: CPHD ... & Drug Administration (FDA) to market its Xpert(R) C. difficile ... of the bacterium that causes Clostridium difficile infection (CDI). ... for CDI to deliver both rapid turnaround and a high degree ...
... , PORT WASHINGTON, N.Y., July 13 ... of the American Medical Association has granted a CPT Category ... (TM) (MCG) system. MCG is the World,s first Internet based, ... for interactive online diagnosis. The MCG is intended as ...
Cached Medicine News:Health News:Gentiva(R) Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday, July 30, 2009 2Health News:Gentiva(R) Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday, July 30, 2009 3Health News:Gentiva(R) Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday, July 30, 2009 4Health News:Sunesis Pharmaceuticals Receives Milestone Payment From Biogen Idec 2Health News:Analysis of Four Large Post-Marketing Surveillance Studies Describe Clinical Effects of Sucrose-Formulated Recombinant Factor VIII 2Health News:Analysis of Four Large Post-Marketing Surveillance Studies Describe Clinical Effects of Sucrose-Formulated Recombinant Factor VIII 3Health News:Analysis of Four Large Post-Marketing Surveillance Studies Describe Clinical Effects of Sucrose-Formulated Recombinant Factor VIII 4Health News:Analysis of Four Large Post-Marketing Surveillance Studies Describe Clinical Effects of Sucrose-Formulated Recombinant Factor VIII 5Health News:Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection 2Health News:Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection 3Health News:Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection 4Health News:Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection 5Health News:AMA Grants New Category III CPT Code to Premier Heart's Multifunction CardioGram(TM) (MCG) 2
... (OSS) from Biomet Inc. offers the ... specifically for orthopaedic surgeons and oncologists ... their patients: significant bone loss, ligamentous ... arthroplasties, and multiple hip revision arthroplasties. ...
DePuy's Shoe Boots are sealed thermoplastic boots that help provide splash protection from microorganisms, particulate matter and body fluids....
... The Nidek NM-200D's compact, lightweight body ... more options to treat more patients, more ... ease of operation and functionality for image ... image data to the compact flash card. ...
... Laboratory is a comprehensive, ... manages specimen data from ... tracking to final cumulative ... is a multi-module system ...
Medicine Products: